You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Carcinoid Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibrosis in Chronic and Delayed Myocardial Infarction

Recruiting
  • Aortic Stenosis
  • +2 more
  • 68Ga-FAPI and 18F-AlF-FAPI PET-MR
  • Edinburgh, Scotland, United Kingdom
    University of Edinburgh
Mar 1, 2023

Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,

Recruiting
  • Carcinoid Syndrome
  • +8 more
  • Randomized: 40 mg Paltusotine
  • Randomized: 80 mg Paltusotine
  • Newport Beach, California
  • +5 more
Jan 3, 2023

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Tricuspid Regurgitation, Tricuspid Valve Disease, Carcinoid Syndrome Trial in London (Transcatheter Tricuspid Valved Stent

Not yet recruiting
  • Tricuspid Regurgitation
  • +3 more
  • Transcatheter Tricuspid Valved Stent Graft
  • London, England, United Kingdom
    Barts Health NHS Trust
Apr 19, 2022

Carcinoid Syndrome Trial in Research Triangle Park (Xermelo)

Completed
  • Carcinoid Syndrome
  • Research Triangle Park, North Carolina
    RTI-HS
Jan 18, 2022

Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

Withdrawn
  • Neuroendocrine Tumors
  • +2 more
  • Telotristat ethyl
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
Feb 9, 2022

Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

Withdrawn
  • Advanced Neuroendocrine Neoplasm
  • Carcinoid Syndrome
  • Retifanlimab
  • Telotristat Ethyl
  • (no location specified)
Sep 23, 2021

Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

Recruiting
  • Carcinoid Syndrome
  • +3 more
  • Dual-Energy Computed Tomography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2021

Neuroendocrine Tumor, Carcinoid Syndrome Trial in Nashville (Enterade®, Functional Assessment of Chronic Illness Therapy for

Terminated
  • Neuroendocrine Tumor
  • Carcinoid Syndrome
  • Enterade®
  • Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0)
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
May 18, 2021

Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Tumor Trial in Detroit (other, procedure, drug)

Recruiting
  • Carcinoid Syndrome
  • Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
  • Carbon C 11 Alpha-methyltryptophan
  • +3 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)

Completed
Has Results
  • Carcinoid Syndrome
  • Los Angeles, California
  • +53 more
Sep 15, 2022

Viral Pneumonia, COVID-19 Pneumonia, Serotonin Syndrome Trial (Cyproheptadine Hydrochloride 4 MG)

Not yet recruiting
  • Viral Pneumonia
  • +3 more
  • Cyproheptadine Hydrochloride 4 MG
  • (no location specified)
May 5, 2021

Viral Pneumonia, Serotonin Syndrome, Platelet Dysfunction Trial (Cyproheptadine Hydrochloride 4 MG)

Not yet recruiting
  • Viral Pneumonia
  • +2 more
  • Cyproheptadine Hydrochloride 4 MG
  • (no location specified)
Mar 31, 2021

Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor Trial (Lutathera)

Not yet recruiting
  • Carcinoid Heart Disease
  • +2 more
  • (no location specified)
Aug 3, 2020

Malignant Carcinoid Syndrome Trial in Tampa (lanreotide Autogel (somatostatin analogue), Sandostatin long acting release (LAR)

Terminated
  • Malignant Carcinoid Syndrome
  • lanreotide Autogel (somatostatin analogue)
  • Sandostatin long acting release (LAR) Depot (somatostatin analogue)
  • Tampa, Florida
    Larry Kvols, MD
Apr 28, 2020

Small Intestinal NET, Carcinoid Heart Disease Trial (Telotristat Ethyl, Lanreotide)

Withdrawn
  • Small Intestinal NET
  • Carcinoid Heart Disease
  • (no location specified)
Jan 30, 2020

Carcinoid Syndrome Trial in Worldwide (BIM 23A760)

Terminated
Has Results
  • Carcinoid Syndrome
  • BIM 23A760
  • Vienna, Austria
  • +53 more
Nov 4, 2020

Assess Neuroendocrine Tumour Patients Currently Treated by

Completed
  • Neuroendocrine Tumors
  • Carcinoid Syndrome
    • Brno, Czechia
    • +56 more
    Nov 4, 2020

    Neuroendocrine Tumors, Carcinoid Syndrome Trial (Sandostatin)

    Terminated
    • Neuroendocrine Tumors
    • Carcinoid Syndrome
    • (no location specified)
    Oct 24, 2019

    Genetics of Appendix Cancer Study

    Recruiting
    • Appendix Cancer
    • +14 more
    • Genetic profiling
    • Retrospective tissue procurement
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Feb 8, 2023

    Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +18 more
    • Clinical Encounter
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jul 24, 2023

    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in San Francisco, Vallejo (bevacizumab, 5-fluorouracil,

    Terminated
    Has Results
    • Gastrointestinal Carcinoid Tumor
    • +4 more
    • bevacizumab
    • +3 more
    • San Francisco, California
    • +1 more
    Dec 12, 2019

    Survival and PN Dependence in SBS Patients

    Completed
    • Short Bowel Syndrome
      • (no location specified)
      Oct 21, 2023

      Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

      Completed
      Has Results
      • Gastrin-Producing Neuroendocrine Tumor
      • +10 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Mar 25, 2020